Vercise Genus, 4th-generation DBS Treatment, Coming Soon to US

Vercise Genus, 4th-generation DBS Treatment, Coming Soon to US

283966

Vercise Genus, 4th-generation DBS Treatment, Coming Soon to US

Vercise Genus, a fourth-generation system for deep brain stimulation (DBS) to treat people with Parkinson’s disease, is now available in the U.S.,  Boston Scientific, which markets the system, announced. The U.S. Food and Drug Administration approved the system’s conditional use with full-body MRI scans, following a similar decision by the European Union in September. A controlled U.S. launch is expected to begin in the coming months. DBS uses surgically implanted pulse generators (IPG, a type of neurostimulator) to…

You must be logged in to read/download the full post.